Results for tag: "Mycosis Fungoides Drug"

Mycosis Fungoides (MF) is a type of cutaneous T-cell lymphoma (CTCL) that is characterized by the presence of malignant T-cells in the skin. Treatment of MF is typically done with systemic therapies, such as chemotherapy, radiation, and immunotherapy. The drug market for MF is composed of a variety of drugs, including monoclonal antibodies, small molecule inhibitors, and other targeted therapies. These drugs are used to treat the disease, as well as to reduce the risk of recurrence. The MF drug market is highly competitive, with a number of companies offering different treatments. Some of the major players in the market include Novartis, Celgene, Merck, Pfizer, and Bristol-Myers Squibb. These companies offer a range of treatments, including monoclonal antibodies, small molecule inhibitors, and other targeted therapies. Additionally, there are a number of smaller companies that offer treatments for MF, such as ImmunoGen, Immunomedics, and ImmunoTherapeutics. Show Less Read more